Redmond facility opens to make monoclonal antibodies and re-imagine drug production

A Redmond lab facility that opened Wednesday will manufacture novel therapeutics and produce COVID-19 monoclonal antibodies for the U.S. Department of Defense

source https://www.seattletimes.com/business/redmond-facility-opens-to-make-monoclonal-antibodies-and-re-imagine-drug-production/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology